MDT

87.86

-1.21%↓

VEEV

221.66

-2.12%↓

A

109.71

-5.41%↓

HQY

82.88

-6.59%↓

PDCO

31.2

-0.22%↓

MDT

87.86

-1.21%↓

VEEV

221.66

-2.12%↓

A

109.71

-5.41%↓

HQY

82.88

-6.59%↓

PDCO

31.2

-0.22%↓

MDT

87.86

-1.21%↓

VEEV

221.66

-2.12%↓

A

109.71

-5.41%↓

HQY

82.88

-6.59%↓

PDCO

31.2

-0.22%↓

MDT

87.86

-1.21%↓

VEEV

221.66

-2.12%↓

A

109.71

-5.41%↓

HQY

82.88

-6.59%↓

PDCO

31.2

-0.22%↓

MDT

87.86

-1.21%↓

VEEV

221.66

-2.12%↓

A

109.71

-5.41%↓

HQY

82.88

-6.59%↓

PDCO

31.2

-0.22%↓

Search

Edwards Lifesciences Corp

Geschlossen

BrancheGesundheitswesen

73.07 1.36

Übersicht

Veränderung der Aktienkurses

24h

Aktuell

Min

70.56

Max

73.22

Schlüsselkennzahlen

By Trading Economics

Einkommen

-2.7B

346M

Verkäufe

31M

1.4B

KGV

Branchendurchschnitt

30.714

63.778

EPS

0.59

Gewinnspanne

24.989

Angestellte

15,800

EBITDA

55M

484M

Empfehlungen

By TipRanks

Empfehlungen

Buy

12-Monats-Prognose

+7.62% upside

Dividenden

By Dow Jones

Nächstes Ergebnis

23. Apr. 2025

Marktstatistiken

By TradingEconomics

Marktkapitalisierung

-1.1B

42B

Vorheriger Eröffnungskurs

71.71

Vorheriger Schlusskurs

73.07

Nachrichtenstimmung

By Acuity

62%

38%

340 / 386 Ranking in Healthcare

Technischer Score

By Trading Central

Vertrauen

Strong Bullish Evidence

Edwards Lifesciences Corp Chart

Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.

Ähnliche Nachrichten

15. Juli 2024, 13:57 UTC

Akquisitionen, Fusionen, Übernahmen

Edwards Lifesciences to Buy Innovalve for $300 Million

25. Okt. 2024, 09:10 UTC

Ergebnisse

These Stocks Are Moving the Most Today: Tesla, Capri, Western Digital, Spirit Airlines, Deckers, Coursera, and More -- Barrons.com

25. Okt. 2024, 08:35 UTC

Ergebnisse

These Stocks Are Moving the Most Today: Tesla, Capri, Western Digital, Spirit Airlines, Deckers, Coursera, and More -- Barrons.com

3. Sept. 2024, 20:38 UTC

Akquisitionen, Fusionen, Übernahmen

Edwards Lifesciences: After Recent Accelerated Repurchase Agreement and August Buybacks Via 10b5-1 Agreement and Open Market Repurchases, Company Has $1.4B in Remaining Authorization

3. Sept. 2024, 20:37 UTC

Akquisitionen, Fusionen, Übernahmen

Edwards Lifesciences Completes Sale of Critical Care Group to Becton Dickinson for $4.2B

3. Sept. 2024, 20:36 UTC

Akquisitionen, Fusionen, Übernahmen

Edwards Lifesciences Authorizes $1.5B of Additional Share Repurchases

25. Juli 2024, 09:02 UTC

Ergebnisse
Heiße Aktien

Stocks to Watch Thursday: Ford, IBM, Chipotle, American Airlines -- WSJ

25. Juli 2024, 08:40 UTC

Top News

These Stocks Are Moving the Most Today: Ford, Tesla, Alphabet, Nvidia, Super Micro, IBM, ServiceNow, Chipotle, and More -- Barrons.com

24. Juli 2024, 20:17 UTC

Ergebnisse

Edwards Lifesciences: Expects 2024 Edwards Sales Growth of 8% to 10% >EW

24. Juli 2024, 20:15 UTC

Akquisitionen, Fusionen, Übernahmen

Edwards Lifesciences Expands Structural Heart Portfolio With Acquisitions of JenaValve and Endotronix

24. Juli 2024, 20:15 UTC

Ergebnisse

Edwards Lifesciences 2Q Sales $1.39B >EW

24. Juli 2024, 20:15 UTC

Ergebnisse

Edwards Lifesciences 2Q Net $366.3M >EW

24. Juli 2024, 20:15 UTC

Ergebnisse

Edwards Lifesciences 2Q Adj EPS 70c >EW

24. Juli 2024, 20:15 UTC

Ergebnisse

Edwards Lifesciences 2Q EPS 61c >EW

15. Juli 2024, 13:42 UTC

Akquisitionen, Fusionen, Übernahmen

Edwards Lifesciences to Buy Innovalve for $300M

15. Juli 2024, 13:01 UTC

Akquisitionen, Fusionen, Übernahmen

Edwards Lifesciences: SAPIEN M3 Remains on Track to Become First Approved Transfemoral TMVR System in Europe by End of 2025 >EW

15. Juli 2024, 13:01 UTC

Akquisitionen, Fusionen, Übernahmen

Edwards Lifesciences: Acquisition Enhances TMVR Technologies to Address Large Unmet Structural Heart Patient Needs >EW

15. Juli 2024, 13:00 UTC

Akquisitionen, Fusionen, Übernahmen

Edwards Lifesciences to Acquire Innovalve Bio Medical Ltd., Early-Stage Transcatheter Mitral Valve Replacement Co >EW

15. Juli 2024, 13:00 UTC

Akquisitionen, Fusionen, Übernahmen

Edwards Lifesciences To Acquire Innovalve >EW

4. Juni 2024, 17:26 UTC

Akquisitionen, Fusionen, Übernahmen

Edwards Lifesciences Deal A Clear Win For Becton Dickinson, Analysts Say -- Analysis

3. Juni 2024, 13:26 UTC

Akquisitionen, Fusionen, Übernahmen

Edwards Lifesciences Stock Nears Breakout On A Surprise $4.2 Billion Deal -- IBD

3. Juni 2024, 12:25 UTC

Top News
Akquisitionen, Fusionen, Übernahmen

Becton Dickinson to Acquire Edwards Lifesciences' Unit for $4.2 Billion in Cash -- Update

3. Juni 2024, 11:03 UTC

Top News
Akquisitionen, Fusionen, Übernahmen

Becton Dickinson to Acquire Edwards Lifesciences' Critical Care Product Group for $4.2B in Cash

3. Juni 2024, 10:40 UTC

Akquisitionen, Fusionen, Übernahmen

Edwards Lifesciences To Sell Its Critical Care Product Group For $4.2 Billion To Becton Dickinson -- MarketWatch

3. Juni 2024, 10:32 UTC

Akquisitionen, Fusionen, Übernahmen

Becton Dickinson: Acquired Business Has About 4,500 Employees >BDX EW

3. Juni 2024, 10:31 UTC

Akquisitionen, Fusionen, Übernahmen

Becton Dickinson: Acquired Business Generated More Than $900 Million Revenue in 2023 >BDX

3. Juni 2024, 10:31 UTC

Akquisitionen, Fusionen, Übernahmen

Becton Dickinson: Deal Expands Portfolio of Smart Connected Care Solutions >BDX EW

3. Juni 2024, 10:30 UTC

Akquisitionen, Fusionen, Übernahmen

Becton Dickinson to Buy Edwards Lifesciences Critical Care Product Group for $4.2 Billion >BDX EW

3. Juni 2024, 10:30 UTC

Akquisitionen, Fusionen, Übernahmen

BD To Acquire Edwards Lifesciences' Critical Care Product Group For $4.2 Billion To Expand Smart Connected Care Solutions And Become An Advanced Monitoring Technology Leader >BDX EW

26. Apr. 2024, 20:10 UTC

Ergebnisse

This 'Critical' Business Helped Edwards Lifesciences Offset Its TAVR Miss -- IBD

Peer-Vergleich

Kursveränderung

Edwards Lifesciences Corp Prognose

Kursziel

By TipRanks

7.62% Vorteil

12-Monats-Prognose

Durchschnitt 77.54 USD  7.62%

Hoch 90 USD

Tief 60 USD

Basierend auf 19 Wall-Street-Analysten, die in den letzten 3 Monaten 12-Monats-Kursziele für Edwards Lifesciences Corp – Dist angeboten haben.

Rating-Konsens

By TipRanks

Buy

19 ratings

7

Buy

11

Halten

1

Sell

Technischer Score

By Trading Central

71.35 / N/AUnterstützung & Widerstand

Kurzfristig

Strong Bullish Evidence

Mittelfristig

Bullish Evidence

Langfristig

Weak Bullish Evidence

Stimmung

By Acuity

340 / 386 Ranking in Gesundheitswesen

Nachrichtenstimmung

Bärische Evidenz

Volatilität

Unterdurchschnittlich

Nachrichtenvolumen (RCV)

Unterdurchschnittlich

Finanzen

Vertriebs- und Verwaltungskosten

Betriebsaufwand

Gewinn vor Steuern

Verkäufe

Umsatzkosten

Bruttogewinn aus dem Verkauf

Zinsaufwand für Schulden

EBITDA

Betriebsergebnis

$

Über Edwards Lifesciences Corp

Edwards Lifesciences Corporation provides products and technologies for structural heart disease and critical care monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of aortic heart valves under the Edwards SAPIEN family of valves system; and transcatheter heart valve repair and replacement products to treat mitral and tricuspid valve diseases under the PASCAL PRECISION and Cardioband names. The company also provides surgical structural heart solutions, such as aortic surgical valve under the INSPIRIS name; INSPIRIS RESILLA aortic valve, which offers RESILIA tissue and VFit technology; KONECT RESILIA, a pre-assembled tissue valves conduit for complex combined procedures; and MITRIS RESILIA valve. In addition, it offers critical care solutions, including hemodynamic monitoring systems to measure a patient's heart function and fluid status in surgical and intensive care settings under the FloTrac, Acumen IQ sensors, ClearSight, Acumen IQ cuffs, and ForeSight names; HemoSphere, a monitoring platform that displays physiological information; and Acumen Hypotension Prediction Index software that alerts clinicians in advance of a patient developing dangerously low blood pressure. The company distributes its products through a direct sales force and independent distributors. Edwards Lifesciences Corporation was founded in 1958 and is headquartered in Irvine, California.